ATE231129T1 - Pharmazeutische pyridin-derivate - Google Patents

Pharmazeutische pyridin-derivate

Info

Publication number
ATE231129T1
ATE231129T1 AT93915498T AT93915498T ATE231129T1 AT E231129 T1 ATE231129 T1 AT E231129T1 AT 93915498 T AT93915498 T AT 93915498T AT 93915498 T AT93915498 T AT 93915498T AT E231129 T1 ATE231129 T1 AT E231129T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
pyridine derivatives
pct
sec
date jun
Prior art date
Application number
AT93915498T
Other languages
English (en)
Inventor
Robert A Daines
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE231129T1 publication Critical patent/ATE231129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93915498T 1992-06-30 1993-06-30 Pharmazeutische pyridin-derivate ATE231129T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90677192A 1992-06-30 1992-06-30
US2519893A 1993-03-02 1993-03-02
PCT/US1993/006234 WO1994000437A1 (en) 1992-06-30 1993-06-30 Pharmaceutical pyridine compounds

Publications (1)

Publication Number Publication Date
ATE231129T1 true ATE231129T1 (de) 2003-02-15

Family

ID=26699422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915498T ATE231129T1 (de) 1992-06-30 1993-06-30 Pharmazeutische pyridin-derivate

Country Status (16)

Country Link
US (1) US5990314A (de)
EP (1) EP0649412B1 (de)
JP (1) JP3230682B2 (de)
KR (1) KR950702185A (de)
CN (1) CN1108247A (de)
AT (1) ATE231129T1 (de)
AU (2) AU4545893A (de)
CA (1) CA2138954A1 (de)
DE (1) DE69332640T2 (de)
ES (1) ES2191014T3 (de)
IL (1) IL106156A0 (de)
MA (1) MA22926A1 (de)
MX (1) MX9303973A (de)
NZ (1) NZ253967A (de)
SI (1) SI9300349A (de)
WO (1) WO1994000437A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3775685B2 (ja) 1993-07-28 2006-05-17 ローン−プーラン・ロレ・リミテツド Ｐｄｅ▲ｉｖ▼およびｔｎｆ抑制剤としての化合物
AU1335795A (en) * 1993-12-08 1995-06-27 Smithkline Beecham Corporation Compounds
CA2178634A1 (en) * 1993-12-09 1995-06-15 Robert A. Daines Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
DK0812194T3 (da) * 1995-03-02 2000-12-18 Smithkline Beecham Corp Fremgangsmåde til behandling af atopisk dermatitis og kontaktdermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
AU4557397A (en) * 1996-09-26 1998-04-17 Novartis Ag Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI925544L (fi) * 1990-06-07 1992-12-07 Smithkline Beecham Corp Bensoesyraderivat foer behandling av leukotrienassocierade sjukdomar
JPH07116150B2 (ja) * 1990-06-07 1995-12-13 スミスクライン・ビーチャム・コーポレイション 安息香酸誘導体
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Also Published As

Publication number Publication date
CA2138954A1 (en) 1994-01-06
AU4545893A (en) 1994-01-24
MX9303973A (es) 1994-04-29
CN1108247A (zh) 1995-09-13
KR950702185A (ko) 1995-06-19
WO1994000437A1 (en) 1994-01-06
DE69332640T2 (de) 2003-11-06
EP0649412A1 (de) 1995-04-26
EP0649412A4 (de) 1995-07-05
NZ253967A (en) 1996-11-26
MA22926A1 (fr) 1994-04-01
AU707102B2 (en) 1999-07-01
EP0649412B1 (de) 2003-01-15
JP3230682B2 (ja) 2001-11-19
AU2280797A (en) 1997-08-14
SI9300349A (sl) 1993-12-31
DE69332640D1 (de) 2003-02-20
US5990314A (en) 1999-11-23
JPH07508284A (ja) 1995-09-14
ES2191014T3 (es) 2003-09-01
IL106156A0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
DE59511017D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
FR2686084B1 (fr) Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
EP0706373A4 (de) In liposomen verkapseltes taxol und verwendungsverfahren
ATE210147T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten(a- oder b-ring-verknüpfung)
SE8804629D0 (sv) New therapeutically active compounds
DE69418461D1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
FR2674524B1 (fr) Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
EE9800318A (et) Leukotrieen-antagonistliku toimega bensopüraanderivaadid
DE69332640D1 (de) Pharmazeutische pyridin-derivate
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
SE8701375D0 (sv) Novel pyridyl- and pyrimidyl derivatives
ATE169019T1 (de) Xanthinderivate als adenosin-a1 rezeptor antagonisten
ATE153336T1 (de) Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ATE203530T1 (de) Adamantyl substituierte oxindole als pharmazeutische wirkstoffe
IT8847797A0 (it) Derivati dell' 1.3 -diossalano e dell'1.3-diossano e loro impiegocome medicamenti
FR2684992B1 (fr) Procede de preparation d'amino-2 nitro-7 benzothiazoles.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties